Pro-Dex, Inc. (NASDAQ:PDEX) Stake Boosted by Dimensional Fund Advisors LP

Dimensional Fund Advisors LP increased its position in shares of Pro-Dex, Inc. (NASDAQ:PDEX) by 5.1% during the 2nd quarter, HoldingsChannel.com reports. The firm owned 63,036 shares of the medical instruments supplier’s stock after purchasing an additional 3,067 shares during the period. Dimensional Fund Advisors LP’s holdings in Pro-Dex were worth $1,238,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Separately, Perritt Capital Management Inc. lifted its stake in Pro-Dex by 43.3% in the first quarter. Perritt Capital Management Inc. now owns 6,000 shares of the medical instruments supplier’s stock valued at $106,000 after buying an additional 1,813 shares during the last quarter. Institutional investors own 15.28% of the company’s stock.

Wall Street Analysts Forecast Growth

PDEX has been the topic of a number of recent research reports. StockNews.com upgraded Pro-Dex from a “buy” rating to a “strong-buy” rating in a research note on Saturday, September 7th. Ascendiant Capital Markets raised their target price on Pro-Dex from $28.00 to $30.00 and gave the company a “buy” rating in a research note on Monday, September 9th.

Pro-Dex Stock Performance

PDEX stock opened at $29.39 on Friday. The company has a debt-to-equity ratio of 0.24, a quick ratio of 1.66 and a current ratio of 2.84. The stock has a market capitalization of $100.48 million, a price-to-earnings ratio of 50.67 and a beta of 0.39. Pro-Dex, Inc. has a 1 year low of $14.51 and a 1 year high of $34.04. The stock’s fifty day moving average is $24.35 and its two-hundred day moving average is $20.75.

Pro-Dex (NASDAQ:PDEX) last issued its quarterly earnings results on Thursday, September 5th. The medical instruments supplier reported $0.46 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.11. The company had revenue of $15.03 million for the quarter. Pro-Dex had a return on equity of 6.82% and a net margin of 3.95%. On average, research analysts predict that Pro-Dex, Inc. will post 1.42 EPS for the current year.

Pro-Dex Profile

Pro-Dex, Inc designs, develops, manufactures, and sells powered surgical instruments for medical device original equipment manufacturers worldwide. The company offers autoclavable, battery-powered and electric, and multi-function surgical drivers and shavers that are primarily used in the orthopedic, thoracic, and craniomaxillofacial markets.